NCT00186277已完成2 期
Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- Tolerability of the this combination in patients with recurrent metastatic bladder cancer.
研究概览
简要总结
To combine oxaliplatin and taxotere in patients who have had prior cisplatin therapy in bladder cancer.
详细描述
To test the combination of oxaliplatin chemotherapy in combination with taxotere chemotherapy in patients with advanced bladder cancer who have failed one prior chemotherapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Tolerability of the this combination in patients with recurrent metastatic bladder cancer.
时间窗: 1 year
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
终止
2 期
Oxaliplatin and Topotecan in Advance Ovarian CancerRecurrent Ovarian Epithelial CancerNCT00313612National Cancer Institute (NCI)39
已完成
2 期
Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to CisplatinNeoplasms, Germ Cell and EmbryonalNCT00611962Sanofi27
已完成
2 期
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical CancerCervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical CarcinomaStage IVA Cervical CancerCervical Squamous Cell CarcinomaStage IVB Cervical CancerNCT00057863National Cancer Institute (NCI)35
已完成
2 期
Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast CancerBreast NeoplasmsNCT00527930Seoul National University Hospital87
终止
2 期
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerHead and Neck CancerCarcinoma, SquamousNCT00591149University of Kansas Medical Center16